ARTICLE | Company News
Neoprobe, Aastrom deal
June 5, 2001 7:00 AM UTC
NEOP will test ASTM's AastromRepliCell System with NEOP's activated lymph node lymphocyte (LNL) technology to treat cancer. If the assessment is successful, NEOP will incorporate the AastromRepliCell ...